ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models

Zhang, Pengfei; Li, Huawei; Cheng, Xiaoguang; Wang, Wei*哈尔滨医科大学
Biomed Research International2022-7-14DOI: 10.1155/2022/9139823
1被引4阅读
引用收藏
分享

摘要

Lung squamous cell carcinoma (LUSC) is the main cause of cancer-related mortality. Some studies demonstrate that m6a and long noncoding RNA (lncRNA) are vital in the pathogenesis of LUSC. In this study, we aimed to further understand the prognostic value of m6a-related lncRNAs in LUSC and their role in the immune microenvironment. For this, we obtained LUSC transcriptome and clinical data from the TCGA database. Further, the identified m6a-related and prognostically relevant lncRNAs were clustered into groups based on prognostic lncRNA expression. Further analysis of the differences between clusters was performed. Five m6A-related lncRNAs were used for model construction using the LASSO regression. The receiver-operating characteristic curve (ROC curves) and decision curve analysis (DCA) were used to assess the model accuracy. Finally, the model was validated using polymerase chain reaction (PCR). We identified 12 m6a-related lncRNAs that were associated with prognosis and were lowly expressed in tumors. Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) highly correlated with prognostic genes, and differential analysis indicated that it was highly expressed in the tumor group and cluster 1. In cluster 2 TIME, tumor cells were less pure and more immune, and stromal-associated cells were present. A prognostic model was constructed based on five m6a-lncRNAs. The area under the curve (AUC) was >0.5 in test group and train group. The PCR results showed that the genes in the prognostic model were lowly expressed in the tumor and were statistically significant (p < 0:05). We noted that m6a-lncRNAs were strongly associated with LUSC prognosis and the immune microenvironment. Thus, PRC1-AS1, AL132780.2, AC013731.1, SNHG30, and AL358472.2 can be considered as new targets for the treatment of patients with LUSC.

学科与关键词

关键词
RNA METHYLATIONCANCERM(6)APROMOTESCTLA-4ROLESCD28
相关
加载中…
  • Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
    Weng, Chengyin; Wang, Lina; Liu, Guolong*; Guan, Mingmei*; Lu, Lin*Frontiers in Oncology, 2021, 11: 763027.被引 12
  • N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
    Zhou, Yang; Guan, Xuhui; Wang, Shuncong; Sun, Huanhuan*; Ma, Haiqing*Journal of Oncology, 2022, 2022: 5240611.
  • The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma
    Huang, Hanwen; Wu, Weibin; Lu, Yiyu*; Pan, Xiaofen*Journal of Thoracic Disease, 2022.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomed Research International
发表日期
2022-07-14
卷期
第 2022 卷
页码
9139823
DOI
10.1155/2022/9139823
语言
ENGLISH
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zhang, Pengfei (第一作者)

    2 · harbin med univ

  • L

    Li, Huawei

    2 · harbin med univ

查看全部 4 位作者收起作者
  • C

    Cheng, Xiaoguang

  • W

    Wang, Wei (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417